The Geraldine Weiss dividend yield theory applied to Bristol-Myers Squibb Company PFD CONV 2 ($BMYMP) uses the stock's historical dividend yield range to estimate when the price is cheap or expensive relative to its own dividend-paying history (2025–2026). Based on that history, $BMYMP is currently trading in overvalued territory.

When the $BMYMP yield climbs above 🟢 0.29%, the stock has historically been undervalued. When the yield falls below 🔴 0.19%, Bristol-Myers Squibb Company PFD CONV 2 has historically been overvalued. The dashed 🟡 fair value (~0.24%) line marks the orientative midpoint between both extremes, not a price target.